Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2021 | Story Lunga Luthuli | Photo Lunga Luthuli
South Campus: Social Responsibility Project team with Free State Department of Health nurses during the lunch of the campus’ COVID-19 pop-up vaccination site.

On Monday 27 September 2021, the University of the Free State, Provincial Department of Health and Department of Education launched a pop-up vaccination site at the South Campus bringing much-needed services closer to communities in the fight to end the COVID-19 pandemic.

Thandeka Mosholi, Head of Social Responsibility, Enterprise and Community Engagement, South Campus says, “We are next to the Mangaung community and bringing these services we encourage not only UFS staff and students but the surrounding communities to vaccinate for COVID-19. The institution and stakeholders are saying it is everyone’s responsibility for their health.”

She says, “If vaccination is recommended and we are told that it is safe, we encourage everyone including the youth to preserve our health and vaccinate.”

Representing the Department of Health, Papi Mokhele, Professional Pharmacist, says, “The initiative is aimed at reaching out to as many people to be vaccinated.”

He says, “At the moment the facility administers only the Pfizer vaccination and, as recommended by the National Government, we want to reach herd immunity – about 70% of the population – so that businesses, sporting facilities and many others can open and get our life back to normal.”

Other facilities the Department of Health has recently opened include the SABC Hoffman Square, Majakathata Taxi Rank, MUCCPP Health Centre in Phelindaba, Puma Garage in Bergman and Mangaung Outdoor Centre.

On partnering with the UFS, Mokhele says, “The COVID-19 vaccines have been put through clinical processes and quality assurance tests. They have also been approved by the South African Medicine Control Council and we call on the UFS community, especially students, to register and vaccinate.”

Coretha van den Heever, Teacher Trainer in the Social Responsibility Project, was recently vaccinated for the pandemic and says, “Let us protect ourselves and other people and not be the spreaders of the virus.”

She says, “People must make use of the facility; the UFS and government have brought the solution closer so that communities will not have to spend a lot of money travelling to get help.”

The vaccination centre will operate from Monday to Friday from 9:00 to 16:00.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept